What is Genome Medical?
Genome Medical operates as a telehealth-based medical practice, leveraging a comprehensive suite of communication tools including face-to-face video, email, texting, shared imaging, and dedicated apps. This model supports and promotes long-distance clinical health care, patient and professional health-related education, and public health administration. Headquartered in South San Francisco, the company aims to broaden access to specialized medical services through its advanced digital platform, positioning itself as a key player in the evolving landscape of remote healthcare solutions.
How much funding has Genome Medical raised?
Genome Medical has raised a total of $120M across 3 funding rounds:
Series A
$23M
Series B
$37M
Series C
$60M
Series A (2017): $23M with participation from HealthInvest Equity Partners, Illumina Ventures, Canaan Partners, and Flywheel Ventures
Series B (2020): $37M led by Revelation Partners, Samsung Electronics America, Kaiser Permanente Ventures, HealthInvest Equity Partners, Manatt Venture Fund, Randy Scott, Casdin Capital, Avestria Ventures, LRVHealth, GE Ventures, Dreamers Fund, Canaan Partners, Illumina Ventures, Flywheel Ventures, Perceptive Advisors, and Echo Health Ventures
Series C (2021): $60M supported by Canaan Partners, Casdin Capital, GV, Perceptive Advisors, Kaiser Permanente Ventures, and Amgen Ventures
Key Investors in Genome Medical
Illumina Ventures
Illumina Ventures is a leader in genomics and precision health investing, focused on building an ecosystem that translates investment into innovation to enhance human health. The company supports various portfolio companies that are advancing life science research, biopharmaceutical drug development, and gene editing technologies.
Canaan Partners
Canaan is an early-stage venture capital firm that invests in technology and healthcare companies, backing founders from seed through growth stages in areas such as enterprise software, fintech, consumer, biopharma, and digital health. With offices in the U.S. and Israel and billions of dollars under management, Canaan has funded hundreds of startups and supported dozens of IPOs and acquisitions.
Kaiser Permanente Ventures
Kaiser Permanente Ventures is a national leader in strategic venture investing in healthcare, focusing on advancing healthcare innovation. The company partners with entrepreneurs to build promising healthcare solutions that provide clear value for patients, providers, and healthcare delivery systems.
What's next for Genome Medical?
With the recent influx of capital, Genome Medical is poised for accelerated expansion and further development of its telehealth services. The substantial enterprise-level backing suggests a strategic focus on scaling operations, enhancing technological capabilities, and potentially broadening its service offerings. This investment will likely fuel initiatives aimed at increasing market penetration, refining the patient and provider experience, and solidifying its position as a leader in genomics-driven telehealth. The company's trajectory indicates a commitment to innovation and accessibility in healthcare.
See full Genome Medical company page
